Baxter to buy Claris Lifesciences’ global generic injectables business
The $ 625 mn deal is a move to boost Baxter’s presence in this space
Author
Sun Pharma completes acquisition of Ocular Technologies Sarl
In October this year, Sun Pharma announced acquisition for a front payment of $40 million
Cipla’s Netherlands arm to form JV with Iranian distributor Ahran Tejarat Company
The 16.8 m euro JV proposes to undertake manufacturing and marketing of pharmaceutical products in Iran
AstraZeneca wins Corporate CSR Best Practices Award at NHRD National Conference
Is also a finalist in the HR Best Practices category for its focus on gender diversity
Natco Pharma launches Tamiflu generic capsules in US
The company's capsules are generic versions of Roches Tamiflu drug
Strides Shasun to acquire Perrigo’s US FDA approved API facility in India
Strides Shasun will acquire 100 per cent of the issued capital of Perrigo API India for a consideration of Rs 1000 million
Prima Nature Care launches sea buckthorn-based phyto-medicines in India
The clinical trials of phyto-medicine have shown remarkable improvements in the conditions of patients with various diseases like…
Biocon features in Asia IP Elite 2016 list
Biocon has built its credibility as an innovation-led enterprise through a track record of IP value creation in discovery,…
Indian pharma industry facing growth headwinds: ICRA
Increasing penetration, accessibility and continued new launches will help Indian pharma industry to grow in the long term
Cipla receives final approval for generic Baraclude tablets
Entecavir tablets are indicated for the treatment of chronic Hepatitis B virus infection